- N4 Pharma has been awarded a feasibility grant from the UK government to co-fund a collaborative project with biologics group MedImmune to explore the manufacture of a prototype nanomedicine.

The project with MedImmune is expected to last for approximately nine months from 1 February 2018, N4 said. It didn't disclose the size of the grant.

Story provided by